✦ LIBER ✦

MiR-106a is an independent prognostic marker in patients with glioblastoma

✍ Scribed by Zhao, S.; Yang, G.; Mu, Y.; Han, D.; Shi, C.; Chen, X.; Deng, Y.; Zhang, D.; Wang, L.; Liu, Y.; Hou, X.; Wang, C.; Wu, J.; Liu, H.; Wang, L.; Zhang, G.; Qi, J.; Fang, X.; Shi, C.; Ai, J.

Book ID: 121458018
Publisher: Duke University Press
Year: 2013
Tongue: English
Weight: 284 KB
Volume: 15
Category: Article
ISSN: 1522-8517
DOI: 10.1093/neuonc/not001

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Microalbuminuria Is an Independent Progn

Microalbuminuria Is an Independent Prognostic Marker in Patients With Established Heart Failure

✍ Humberto Villacorta; Paula V. Ferradaes; Evandro T. Mesquita 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 110 KB

HE4 is an independent prognostic marker

HE4 is an independent prognostic marker in endometrial cancer patients

✍ Irene Mutz-Dehbalaie; Daniel Egle; Siegfried Fessler; Michael Hubalek; Heidi Fie 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 431 KB

TRAIL-receptor expression is an independ

TRAIL-receptor expression is an independent prognostic factor for survival in patients with a primary glioblastoma multiforme

✍ Jos MA Kuijlen; Jan Jakob A Mooij; Inge Platteel; Eelco W Hoving; Winette TA van 📂 Article 📅 2006 🏛 Springer US 🌐 English ⚖ 551 KB

CD24 Expression is an Independent Progno

CD24 Expression is an Independent Prognostic Marker in Cholangiocarcinoma

✍ Shefali Agrawal; Boris W. Kuvshinoff; Thaer Khoury; Jihnhee Yu; Milind M. Javle; 📂 Article 📅 2007 🏛 Springer-Verlag 🌐 English ⚖ 178 KB

193 MiR-187 is an Independent Prognostic

193 MiR-187 is an Independent Prognostic Factor in Breast Cancer

✍ L. Mulrane; S. Madden; G. Gremel; R. Bernards; K. Jirstrom; D. Higgins; W.M. Gal 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 57 KB

Ribosomal DNA methylation in patients wi

Ribosomal DNA methylation in patients with endometrial carcinoma : An independent prognostic marker

✍ Matthew A. Powell; David G. Mutch; Janet S. Rader; Thomas J. Herzog; Tim Hui-Min 📂 Article 📅 2002 🏛 John Wiley and Sons 🌐 English ⚖ 823 KB

## Abstract ## BACKGROUND Surgery is curative for the majority of patients with endometrial carcinoma: Consequently, the use of adjuvant therapy has been controversial. More effective methods to identify patients who are at risk for recurrence and who would benefit from adjuvant therapy are needed